Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
08/2005
08/04/2005WO2005070207A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/04/2005WO2005051917B1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
08/04/2005WO2005037199A3 Pyrazole derivatives as cannabinoid receptor modulators
08/04/2005WO2004075840A9 Selective non-steroidal glucocorticoid receptor modulators
08/04/2005WO2004008837A9 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
08/04/2005US20050171357 Process for preparing indolinone derivatives
08/04/2005US20050171350 Benzhydryl derivatives
08/04/2005US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/04/2005US20050171346 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections
08/04/2005US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/04/2005US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
08/04/2005US20050171183 Indole-type inhibitors of p38 kinase
08/04/2005US20050171181 Histamine-3 receptor modulators
08/04/2005US20050171178 Exo-1-methyl-1H-imidazole-4-sulfonic acid {3-[6-ethyl-3-(2-hydroxy-indan-2-ylmethyl)-3-aza-bicyclo[3.1.0]hex-6-yl]-phenyl}-amide; opioid receptors (mu, kappa and delta) antagonists; not substrate of the variable enzyme CYP2D6; addiction to an opiates, alcohol; obesity
08/04/2005US20050171156 Prodrugs of potassium channel inhibitors
08/04/2005US20050171154 Carboxylic acid amides
08/04/2005US20050171143 selective Chemoattractant receptor-homologous molecule expressed on Th2 cells ( CRTH2 receptor) antagonist; activities for eosinphil and basophil infiltration; indol/carbazol-sulfonamide derivatives; antiallergenic agent; asthma, allergic rhinitis and dermatitis, polyarteritis, autoimmune disease
08/04/2005US20050171134 such as 4-[4-(1-Amino-1-methylethyl)phenyl]-5-chloro-N-[4-(2-hydroxyethyl)phenyl]pyrimidine-2-amine used as tyrosine kinase inhibitors, for prophylaxis disease states associated with angiogenesis
08/04/2005US20050171132 Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists
08/04/2005US20050171131 Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists
08/04/2005US20050171123 Quinazoline derivatives as medicaments
08/04/2005US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors
08/04/2005US20050171105 Methods and compositions as protein kinase inhibitors
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
08/04/2005US20050171085 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
08/04/2005US20050169844 Near infrared imaging agent
08/04/2005CA2554233A1 Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect
08/04/2005CA2553513A1 N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors
08/04/2005CA2552350A1 Bis-indole pyrroles useful as antimicrobials agents
08/03/2005EP1559714A1 Process for the preparation of 2-alkyl-3-aminothiophene derivatives and 3-aminothiophene derivatives
08/03/2005EP1559710A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV, process for their preparation and their use
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1559446A1 Treating agent for diarrhea-predominant irritable bowel syndrome
08/03/2005EP1558608A1 Oxindole substituted piperazine derivatives
08/03/2005EP1558602A2 2-pyrrolidones as ep4 receptor agonists
08/03/2005EP1558598A1 Triazole compounds for the treatment of dysmenorrhoea
08/03/2005EP1558591A2 Modulation of anxiety through blockade of anandamide hydrolysis
08/03/2005EP1558583A1 Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists
08/03/2005EP1558581A2 Triazolone and triazolethione derivatives
08/03/2005EP1558578A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
08/03/2005EP1558341A2 Transcription factor modulating compounds and methods of use thereof
08/03/2005EP1558260A2 Quinazolinone compounds as calcilytics
08/03/2005EP1558248A1 Derivatives of [6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide as anti-inflammatory agents
08/03/2005EP1558083A2 Compounds, compositions, and methods
08/03/2005EP1284737B1 Water soluble prodrugs of azole compounds
08/03/2005EP1087948B1 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
08/03/2005CN1649929A Low-viscosity polyisocyanate composition having high functionality and method for preparing same
08/03/2005CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
08/03/2005CN1649864A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649849A Tachykinin receptor antagonists
08/03/2005CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF)
08/03/2005CN1649847A Method for producing optically active sulfoxide derivative
08/03/2005CN1649846A Compounds of the family of 3-alkyl-(4, 5-diphenyl-imidazol-1-yl) and their use as soothing agents
08/03/2005CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
08/03/2005CN1649830A Substituted aryl ketones
08/03/2005CN1649612A Induction method for cell differentiation
08/03/2005CN1648125A Heterocyclic compound containing double pyrazole, preparing method and its use
08/03/2005CN1648124A Double heterocyclic compound containing pyrazole and pyrazole ketone, preparing method and its use
08/03/2005CN1648123A Double heterocyclic compound containing pyrazole and benzimidazole, preparing method and its use
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213036C Novel amide derivatives
08/03/2005CN1213035C 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
08/03/2005CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
08/03/2005CN1213026C Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
08/02/2005US6924396 α-haloenamine reagents
08/02/2005US6924330 Thioimidazolidine derivatives as light stabilizers for polymers
08/02/2005US6924305 Diazocine derivatives and their use as tryptase inhibitors
08/02/2005US6924298 Useful as insecticides and acaricides
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
08/02/2005US6924296 Antithrombotic agents
08/02/2005US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
08/02/2005US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc.
08/02/2005US6924285 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
08/02/2005US6924284 PARP inhibitors
08/02/2005US6924281 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
08/02/2005US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases
08/02/2005CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/02/2005CA2102960C Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds
07/2005
07/28/2005WO2005068468A2 Heterocyclic protein kinase inhibitors and uses thereof
07/28/2005WO2005068455A1 Indolylmaleimde derivatives as pkc inhibitors
07/28/2005WO2005068454A1 Indolylmaleimide derivatives
07/28/2005WO2005068453A2 Crystalline forms of rizatriptan benzoate
07/28/2005WO2005068452A1 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors
07/28/2005WO2005068446A1 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof
07/28/2005WO2005068437A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis
07/28/2005WO2005068436A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
07/28/2005WO2005068433A1 Benzimidazole derivatives
07/28/2005WO2005068432A1 Malononitrile compound as pesticides
07/28/2005WO2005068424A1 Indolinone derivatives as receptor tyrosine kinase ihibitors
07/28/2005WO2005067932A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
07/28/2005WO2005067923A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
07/28/2005WO2005067922A1 A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-one hydrochloride
07/28/2005WO2005067644A2 Conjugated small molecules
07/28/2005WO2005032490A3 Cyclic diamines and derivatives as factor xa inhibitors
07/28/2005WO2005016875A3 Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein kinase inhibitors
07/28/2005WO2004098498A3 Indole acetic acid derivatives and their use as pharmaceutical agents
07/28/2005WO2004060306A3 Anti-inflammatory medicaments
07/28/2005US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles
1 ... 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 ... 626